As Delta takes control, US resumes use of Lilly's Covid-19 mAb combo nationwide
A little more than two months after the US halted all shipments of Eli Lilly’s monoclonal antibody combo for the treatment of Covid-19 on …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.